Fixed drug eruption caused by dimenhydrinate

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 55, Issue 3, 2000, Pages 297-

  Saenz De San Pedro, B ^a   Quiralte, J ^b   Florido, J F ^b  

^a Hosp Univ Ciudad de Jaén   (Spain)

^b NONE

Author keywords

Dimenhydrinate; Fixed drug eruption; Oral challenge; Patch test

Indexed keywords

CETIRIZINE; CHLORPHENIRAMINE; DIMENHYDRINATE; DIMETHYL SULFOXIDE; DOXYLAMINE; DRUG VEHICLE; EBASTINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROXYZINE; LORATADINE; MIZOLASTINE; PETROLATUM; TERFENADINE;

AGED; ARTICLE; CASE REPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ERUPTION; ERYTHEMA; HUMAN; MALE; MOTION SICKNESS; PATCH TEST; PRIORITY JOURNAL; PROVOCATION TEST; PRURITUS; SINGLE BLIND PROCEDURE;

EID: 0034061534     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2000.00545.x     Document Type: Article

References (4)

1. HOGAN DJ, ROONEY ME. Fixed drug eruption due to dimenhydrinate. J Am Acad Dermatol 1989;20:503-504.
2. HATZIS J, NOUTSIS K, HATZIDAKIS E, et al. Fixed drug eruption in a mother and her son. Cutis 1992;50:49-52.
3. GONZALO-GARIJO MA, REVENGA-ARRANZ F. Fixed drug eruption due to dimenhydrinate. Br J Dermatol 1996;135:661-662.
4. SMOLA H, KRUPPA A, HUNZELMANN N, et al. Identification of dimenhydrinate as the causative agent in fixed drug eruption using patch-testing in previously affected skin. Br J Dermatol 1998;138:920-921.